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Polymer carriers like PEI which proved their efficiency in DNA delivery were found to be far less effective for
the applications with siRNA. In the current study, we generated a number of nontoxic derivates of branched PEI
through modification of amines by ethyl acrylate, acetylation of primary amines, or introduction of negatively
charged propionic acid or succinic acid groups to the polymer structure. The resulting products showed high
efficiency in siRNA-mediated knockdown of target gene. In particular, succinylation of branched PEI resulted in
up to 10-fold lower polymer toxicity in comparison to unmodified PEI. Formulations of siRNA with succinylated
PEI were able to induce remarkable knockdown (80% relative to untreated cells) of target luciferase gene at the
lowest tested siRNA concentration of 50 nM in Neuro2ALuc cells. The polyplex stability assay revealed that
the efficiency of formulations which are stable in physiological saline is independent of the affinity of siRNA to
the polymer chain. The improved properties of modified PEI as siRNA carrier are largely a consequence of the
lower polymer toxicity. In order to achieve significant knockdown of target gene, the PEI-based polymer has to
be applied at higher concentrations, required most probably for sufficient accumulation and proton sponge effects
in endosomes. Unmodified PEI is highly toxic at such polymer concentrations. In contrast, the far less toxic
modified analogues can be applied in concentrations required for the knockdown of target genes without side
effects.
INTRODUCTION
Since double-stranded RNA molecules were identified as the
mediator of gene silencing in C. elegans (1), RNA interference
(RNAi) has become a powerful strategy for intervention also
in mammalian cell processes and treatment of various diseases,
due to its ability to silence gene expression in a sequence-
specific manner (2–4).
Polycations such as polyethylenimine (PEI)1 have been
introduced as nonviral gene carriers with a capability of forming
stable complexes by electrostatic interactions with nucleic acids.
The polyplex formation leads to improved protection of the
genetic material from enzyme-mediated digestion and enhanced
intracellular delivery. PEI, although it is known to be a powerful
agent in plasmid-based gene delivery (5, 6), has been shown to
be less effective in siRNA-mediated gene silencing (7, 8).
Moreover, it is known to be toxic when applied at higher doses.
The toxicity is mainly associated with a strong positive charge
of this polycation, which leads to strong interaction of PEI with
cell surfaces and their damage. Therefore, modifications of
polymeric backbone that reduce the positive charge of PEI might
be useful in order to reduce the toxicity of the polymer.
Several approaches have already been investigated in this
direction. Different polymeric forms of PEI are available,
the linear form (obtained via polyisoxazoline precursors) or
the branched form (obtained from acid-catalyzed polymeri-
zation of aziridine), both in various degrees of polymerization
that influence their biological activities (9–12). Backbone
modification of linear PEI 22 kDa, which on its own is one
of the most potent transfection agents (6), have reduced the
high gene transfer activity (13). In fact, it was demonstrated
that the high activity depends on complete removal of
propionamide residues from the polyisoxazoline precursor
polymer (14). Linear PEI22 on its own has limited efficiency
in siRNA delivery (7); the activity however can be enhanced
with concatemerizing “sticky” siRNA (ssiRNA) applied for
polyplex formation (15).
Experiences with branched PEI 25 kDa gave different trends.
Interestingly, partial acetylation of PEI amino groups was shown
to enhance gene transfer activity (16). N-Acylation of PEI
lowered its toxicity (17). Also, conjugation of acetate, butanoate,
and hexanoate to branched PEI at low degree of substitution
(below 25%) resulted in moderate improvement of transfection
activity as demonstrated by Putnam and colleagues (18). The
same research group compared different (linear and branched)
PEIs for siRNA transfer activity; only branched PEI within a
narrow window of conditions was able to mediate in vitro gene
silencing in a (HR5-CL11) cell line (8). Reducing the surface
charge of polyplexes by PEGylation of PEI positively affected
the siRNA delivery capacity in the absence (19) or in the
presence of a cell targeting molecule (20).
In this work, using relatively simple modification strategies,
we were able to produce a number of branched PEI derivates,
which were aimed at screening the positive charge of the
polymer. In particular, negative charges were introduced into
the polymer backbone by modification with succinic anhydride
or Michael addition of ethyl acrylate followed by ester hydroly-
sis. Alternatively, amino groups were modified by acetylation
or addition by ethyl acrylate. As was expected, all the products
showed reduced toxicity in comparison to unmodified PEI.
Moreover, we found that several modifications were able to
greatly improve the siRNA/PEI formulation characteristics and
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silencing activities, thereby presenting easy access to promising
siRNA transfection reagents.
EXPERIMENTAL SECTION
Materials. Ethyl acrylate (EA), acetic anhydride, and succinic
anhydride were obtained from Sigma (Munich, Germany). The
plasmid pEGFPLuc (Clontech Laboratories, Heidelberg, Ger-
many) containing a CMV promoter-driven fusion of the genes
encoding for enhanced green fluorescent protein and luciferase
was used for generation of stably transfected cells. Branched
PEI with an average molecular weight of 25 kDa (PEI) was
obtained from Sigma-Aldrich (Munich, Germany). PEI was used
as a 1-10 mg/mL stock solution neutralized with HCl. All other
chemicals were purchased by Sigma-Aldrich (Munich, Ger-
many). Cell culture media, antibiotics, and fetal calf serum
(FCS) were purchased from Invitrogen (Karlsruhe, Germany).
Ready to use siRNA duplexes were purchased from MWG-
Biotech (Ebersberg, Germany), namely, luciferase-siRNA; GL3
luciferase duplex; 5′-CUUACGCUGAGUACUUCGAdTdT-3′;
control-siRNA; nonspecific control duplex with similar GC
content as antiluciferase-siRNA; 5′-AUUGUAUGCGAUCG-
CAGACdTdT-3′.
Modification of PEI by Ethyl Acrylate (EA). About 1 g of
PEI was dissolved in chloroform. The solution was heated to
40 °C. The desired amount of acrylate was added to the solution
with stirring. The reaction proceeded for at 40 °C. After 4 h,
the chloroform was removed by rotary evaporator. The waxy
product was dissolved in 15 mL water and neutralized by HCl
to the pH 4-5 and freeze-dried. The modification degree was
analyzed by 1H NMR in D2O on a Jeol JNMR-GX400 (400
MHz) or Jeol JNMR-GX500 (500 MHz) spectrometer from the
ratio between the peaks of PEI (δ 2.6-3.6 ppm) and methyl
acrylate (δ ) 1.3 ppm). The modification degree was expressed
as a number of modifications per monomer unit of PEI× 100%.
According to FTIR spectra recorded on a Jasco FT/IR-410
spectrometer (Jasco Labor- and Datentechnik GmbH, Germany),
a pronounced ester peak (1730 cm-1) was detected. No
significant amide band (1652 cm-1) was found.
Synthesis of Acetylated and Succinylated PEI. PEI (0.5
g) was dissolved in 8.5 mL of water and 1.5 mL of NaCl
solution (3 M) and then adjusted to pH 5 using 1 M HCl. The
desired amounts of acetic or succinic anhydride were dissolved
in DMSO and added dropwise to PEI solution. The reaction
was carried out at room temperature for 3 h. The crude products
dialyzed (18 000 cutoff, Spectra/Por membrane) first against
0.25 M NaCl solution to remove unreacted acetate or succinate,
and then twice against water at 4 °C to remove salt. After the
dialysis, the aqueous solution was lyophilized. The modification
degree was analyzed by 1H NMR in D2O from the ratio between
the peaks of PEI (δ 2.6-3.6 ppm) and methylene of succinate
(δ ) 2.5 ppm) or methyl of acetate (δ ) 2.1 ppm). The
modification degree was expressed as a percentage of modified
amines of PEI under the assumption that each amine is able to
react.
Synthesis of Propionic Acid Modified PEI by Hydro-
lysis of EA Modified PEI. About 0.3 g of PEI-EA polymer
was dissolved in 1 M HCl. The solution was incubated at 40
°C for 3 days. The final product was dialyzed against water
(18 000 cutoff, Spectra/Por membrane) and freeze-dried. The
extent of reaction was controlled by 1H NMR in D2O. No ethyl
peak was found for all samples, indicating complete hydrolysis
of the ester bond. Neither ester (1730 cm-1) nor amide (1652
cm-1) peak was detected by FTIR.
Polyplex Formation. In all studies, the composition of
polyplexes was characterized by the w/w ratio of the polymer
to nucleic acid in the mixture. The weight of unmodified PEI
represents a weight of the polymer in base form. The weight of
modified PEI represents the weight of lyophilized product, which
was previously neutralized to pH of about 4-5 and, therefore,
includes the mass of counterions (chloride). Formulations for
pDNA and siRNA delivery were prepared in HBG (20 µL) as
follows: First, different concentrations of the nucleic acid and
PEI derivatives were diluted at various polymer/nucleic acid
ratios (w/w: weight/weight) in separate tubes in HBG (HEPES-
buffered glucose solution; 20 mM HEPES, 5% glucose). Then,
the HBG solution of PEI was added to the HBG solution of the
nucleic acid, mixed, and incubated for 30 to 40 min at room
temperature to form stable polymer/nucleic acid complexes.
EtBr Exclusion Assay. The ability of the products to
condense DNA or siRNA was studied using an ethidium
bromide (EtBr) assay. Polymer solution was added stepwise to
the solution of nucleic acid (10 µg/mL) in HBG containing EtBr
(0.4 µg/mL). After each step, fluorescence intensity was
monitored (λex ) 510 nm, λem ) 590 nm). The fluorescence
intensity of the EtBr solution in the presence of free nucleic
acid corresponded to 0% condensation, whereas the fluorescence
intensity without nucleic acid corresponded to 100% condensation.
Polyplex Stability Assay. Polyplexes were mixed with DNA
or siRNA in HBG at a final concentration of 20 µg/mL of
nucleic acid and a 1:1 w/w ratio. The particle sizes were
monitored by dynamic laser light scattering using a Malvern
Zetasizer 3000HS (Malvern Instruments, Worcestershire, UK).
After this, 3 M NaCl solution was added stepwise to the
polyplex solution. After each step, the correlation functions and
scattering intensities were monitored. The dissociation of
polyplexes led to the drop of scattering intensity to the level of
the salt buffer and changes in correlation function (Supporting
Information Figure 1). The NaCl concentration at which the
dissociation of the polyplexes occurred was related to the
stability of the polyplexes.
Cell Culture. For pDNA and siRNA delivery experiments,
mouse melanoma cells B16F10, mouse glioblastoma cells
Neuro2A, Neuro2A/EGFPLuc cells, and HUH7/EGFPLuc cells
stably transfected with the EGFPLuc gene (see below) were
used. B16F10 cells and Neuro2A/EGFPLuc cells were grown
in Dulbecco’s modified Eagle’s medium (DMEM) and HUH7/
EGFPLuc were grown in DMEM/Ham’s F-12 medium, whereby
all media were supplemented with 10% FCS, 4 mM stable
glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin.
All cells were seeded 24 h prior to pDNA or siRNA delivery
using 5000 cells per well in 96-well plates for analysis of protein
expression.
For the generation of stably transfected cells, the vector
pEGFPLuc (Clontech) was linearized using the restriction
enzyme Dra III, and cells were then transfected with this
linearized vector using linear polyethylenimine 22 kDa (PEI
22lin; Euromedex, Souffelweyersheim, France).
Following gene transfer, Neuro2A or HUH7 cells were
incubated in fresh medium for 72 h prior to selection of the
stably transfected cells with 200 to 2000 µg/mL G418 (gene-
ticine; Invitrogen, Karlsruhe, Germany). After several days,
surviving cells were seeded at low density into 6-well plates in
order to generate separate colonies. Single cell clones were then
isolated and expanded. The generated clones were analyzed for
the percentage of EGFP-positive (EGFPLuc stably transfected)
cells by flow cytometry. Clones with the highest number of
EGFP-positive cells were then further selectively grown up
under the above-described selective conditions, and this pro-
cedure was repeated until all cells were positive for EGFP. These
stably transfected cells expressing approximately 60 ng lu-
ciferase per million cells were then used for siRNA delivery
experiments.
In Vitro Gene Transfer. In vitro transfection efficiency of
the polymers was evaluated in B16F10 or Neuro2A cells using
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pEGFPLuc (200 ng pDNA per well). In all experiments, pDNA
delivery was performed in 96-well plates with 5000 cells
(B16F10) or 10 000 cells (Neuro2A) per well in triplicates. Cells
were seeded 24 h prior to transfection and then medium was
replaced with 80 µL fresh growth medium containing 10% FCS.
Transfection complexes for pDNA delivery (20 µL in HBG) at
different w/w ratios were added to each well and incubated at
37 °C. After 4 h, the medium was replaced by fresh growth
medium. The cells were treated with 50 µL cell lysis buffer
(25 mM Tris, pH 7.8, 2 mM EDTA, 2 mM DTT, 10% glycerol,
1% Triton X-100) 24 h following pDNA transfection. Luciferase
activity in cell lysate (20 µL) was measured using a luciferase
assay kit (100 µL Luciferase Assay buffer, Promega, Mannheim,
Germany) on a luminometer for 10 s (Lumat LB9507 instru-
ment, Berthold, Bad Wildbad, Germany).
In Vitro Gene Silencing with siRNA. In vitro gene silencing
experiments were performed in stably transfected Neuro2A/
EGFPLuc and HUH7/EGFPLuc cells using LucsiRNA and
MutsiRNA as a control. In all experiments, siRNA delivery was
performed in 96-well plates with 5000 cells per well in triplicate.
Cells were seeded 24 h prior to transfection, and then medium
was replaced with 80 µL fresh growth medium containing 10%
FCS. Transfection complexes for siRNA delivery (20 µL in
HBG) at different w/w ratios were added to each well and
incubated at 37 °C without medium change. Cells were washed
with phosphate-buffered saline (PBS) and treated with 50 µL
cell lysis buffer (25 mM Tris, pH 7.8, 2 mM EDTA, 2 mM
DTT, 10% glycerol, 1% Triton X-100) 48 h following siRNA
transfection. Luciferase activity in cell lysate (20 µL) was
measured using a luciferase assay kit (100 µL luciferase assay
buffer, Promega, Mannheim, Germany) on a luminometer for
10 s (Lumat LB9507 instrument, Berthold, Bad Wildbad,
Germany). The relative light units (RLU) were related to
untreated control cells.
Cytotoxicity Assay. Neuro2A cells were seeded into 96-well
plates at a density of 1 × 104 cells/well. After 24 h, the culture
medium was replaced with 100 µL/well of serial dilutions of
polymer stock solutions in growth medium. Alternatively,
transfection complexes for pDNA delivery (20 µL in HBG) at
different C/P ratios were added. All studies were made in
triplicate. After 4 h incubation, the medium was replaced by
the fresh one.
After 24 h, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide) (Sigma-Aldrich, Germany) was dis-
solved in phosphate buffered saline at 5 mg/mL, and 10 µL
aliquots were added to each well reaching a final concentration
of 0.5 mg MTT/mL. After an incubation time of 1 h, unreacted
dye with medium was removed. The purple formazan product
was dissolved in 100 µL/well dimethyl sulfoxide and quantified
by a plate reader (Tecan, Groedig, Austria) at 590 nm with
background correction at 630 nm. The relative cell viability (%)
relative to control wells containing cell culture medium without
polymer was calculated by [A] test/[A] control × 100.
RESULTS
Synthesis of the Polymers. The strategies for modification
of branched PEI 25 kDa are presented in Figure 1. In EA and
PROP series, the primary amines of PEI were transformed to
the secondary amines by Michael addition. In AC and SUC
series, the primary amines were acetylated to amides. Addition-
ally, PROP and SUC series have carboxylic group in the
structure.
Syntheses and characterization are described in Materials and
Methods and Supporting Information. PEI was modified with
ethyl acrylate via Michael addition performed at 40 °C and
relatively short incubation time. Table 1 shows the degrees of
modification (12-31%) depending on the ratios in the feed.
Longer incubation times are known to cause aminolysis of ester
bond and lead to cross-linking of PEI (21). No amide peak was
found on FTIR spectra of all polymer samples of PEI-EA series
(data not shown). Therefore, no aminolysis was observed,
excluding the cross-linking of PEI. No double bond peak was
present in 1H NMR for all samples, indicating the complete
evaporation of unreacted acrylate during freeze-drying procedure
and its absence in the final products.
The 3-propionic acid-modified B-PEI (PEI-PROP) was
generated by acid hydrolysis of PEI-EA polymers. Complete
hydrolysis was verified by disappearance of the ester protons
in the NMR spectra and characteristic FTIR-band at 1730 cm-1.
The degrees of PEI modification with carboxylic groups were
assumed to be the same as in nonhydrolyzed precursor polymers.
An absence of the amide peak on FTIR spectra (1652 cm-1)
reveal no significant cross-linking during hydrolysis.
The modification of PEI with acetic anhydride and succinic
anhydride was performed in the presence of salt in the reaction
solution to avoid precipitation of the polymer. The purification
of polymers via dialysis was performed against salt buffer to
ensure complete exchange of acetic or succinic acid, respec-
tively, against chloride. At low reagent/amine feed ratios
(10-20%), nearly quantitative modification of PEI was achieved
(Table 1).
The yields were typically 80-120%. The neutralization of
the products and, consequently, the weight gain due to coun-
terions (chloride), which was not taken into account by
calculation of theoretical yields, was the reason for some of
the yields being above 100%.
The pH titrations of the polymers demonstrated that the pH5
to pH7 buffer capacity did not significantly change after
modification (data not shown).
Toxicity of the Polymers. The cell culture cytotoxicity
profiles of modified PEIs (Figure 2) are shifted to higher
polymer concentrations in comparison to PEI, demonstrating a
Figure 1. Strategies for modification of branched PEI.
Table 1. Composition of Modified PEIsa
polymer reagent/amine*100%, feed modification degree, %
PEI-EA 12 13% 11.5%
PEI-EA 18 26% 17.6%
PEI-EA 31 52% 31%
PEI-PROP 12 n.a. 11.5%
PEI-PROP 18 n.a. 17.6%
PEI-PROP 31 n.a. 31%
PEI-AC 12 10% 12.3%
PEI-AC 22 20% 21.8%
PEI-SUC 9 10% 8.9%
PEI-SUC 19 20% 19.4%
a The nomenclature of the polymers is expressed as follows: PEI-X Y,
where X represents the reagent by which PEI was modified (EA, ethyl
acrylate; SUC or AC, succinic or acetic anhydride, respectively) or
functional group (PROP for 3-propionic acid) and Y represents the
modification degree of the amines measured by NMR.
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decrease in toxicity. Relatively soft neutral modifications (EA
and AC) have shown only moderate improvement of cell
viability, whereas the incorporation of negative charges on PEI
led to polymers with far less toxicity.
Chemical and Biophysical Properties of Polyplexes. In salt-
free buffer, all polymers were effective in binding of siRNA
(Figure 3) as well as DNA (data not shown). In comparison to
PEI, the binding required higher polymer to siRNA and DNA
(w/w) ratios. Such a difference is caused by the fact that for
modified PEI w/w ratio was calculated from the base form.
Modified PEIs were weighed in neutralized form; therefore, the
counter ions (chloride) markedly contribute to mass per charge
ratio. Nevertheless, at w/w ratio of 2 even the polymers with a
high degree of modification show the reduction of EtBr
fluorescence to less than 10%. No significant difference in
binding between products of different modifications was ob-
served in this assay. Agarose gel electrophoresis data confirmed
these results (data not shown).
The analysis of the polyplex solutions mixed in HBG at w/w
ratios of 2 and 4 by photon correlation spectroscopy did not
show the formation of nanoparticles in the usual 30-300 nm
range of standard DNA/PEI polyplexes. The scattering intensity
from polyplex solution at a concentration of 5 µg/mL based on
siRNA was close to that of HBG buffer, which indicates very
small polyplex sizes and low aggregation number of the polymer
chains. Such behavior of siRNA/PEI polyplexes has recently
been shown by Meyer et al. (22) where particle sizes of around
25 nm were detected by fluorescent correlation spectroscopy.
The increase of the salt concentration in this solution to 150
mmol NaCl led to continuous aggregation of the initial
polyplexes and formation of nanoparticles (around 500 nm after
30 min) in the case of modified PEI. Unmodified PEI without
siRNA did not show any aggregation at physiological saline.
Plasmid-Based Gene Transfer. Most of the polymers were
found to be effective gene transfer agents and showed trans-
fection efficiencies comparable to branched PEI on B16F10 and
Neuro2A cells (Supporting Information Figure 2). Only PEI-
PROP-31 displayed relatively low efficiency. All others showed
transfection efficiencies comparable to PEI. The polyplexes
generated with the modified PEIs induce much less toxicity than
PEI. As can be seen from Supporting Information Figure 2b,c,
at w/w ratio of 4 the cell viabilities are above 80% for the
modified PEI and only 20-40% for the unmodified PEI.
Gene Silencing with siRNA. Modified PEIs were found to
be good DNA transfection agents. However, it is known from
literature that efficient carriers of plasmid DNA are not
necessarily effective for siRNA delivery (23). Linear polyeth-
ylenimine 22 kDa and branched polyethylenimine 25 kDa (PEI),
the powerful DNA delivery agents, showed only limited
efficiency in siRNA delivery (7, 8). Therefore, the modified PEIs
were tested for their efficiency in siRNA delivery using a
neuroblastoma cell line stably transfected with a luciferase
marker gene. The results are presented in Figure 4. Luciferase
activities were determined for cells treated either with LUC
siRNA (directed against the target mRNA) or with a control
siRNA (Mut siRNA), and compared with the luciferase activity
of untreated control cells. Knockdown effects are real when
expression decreases with Luc siRNA but not Mut siRNA. If
luciferase expression decreases with both target and control
siRNA, “knockdown” is mainly due to unspecific carrier
toxicity. siRNA formulations with PEI were not able to facilitate
knockdown of reporter gene without toxicity. High toxicity was
observed for the formulations above w/w ratio of 1, indicated
by decrease of luciferase level for formulations with mismatched
siRNA.
Most modified PEIs (except PEI-PROP-31 and PEI-SUC-
19) showed up to 80-90% of luciferase knockdown, when
formulated with Luc-siRNA. The effect cannot be attributed to
the toxicity of polyplexes, since the luciferase level by the
formulations with mismatched siRNA was close to the control.
Figure 2. Cell viability of Neuro2A cells as a function of concentration of modified PEI polymers in the medium. (a) PEI-EA series, (b) PEI-PROP
series, (c) PEI-AC series, (d) PEI-SUC series.
Figure 3. EtBr exclusion assay of the polymers with siRNA in HBG
buffer.
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The best knockdown was achieved with PEI-SUC-9. Being
nontoxic at all studied mixing ratios, it showed the gene
silencing to almost less than 10% relative to the control. Further
increase of the negative charge on PEI led to inactivation of
this polymer; PEI-SUC-19 did not show any gene knockdown
at all w/w ratios. Interestingly, PEI-EA-31 showed significant
knockdown at w/w of 4 and 6, whereas the hydrolyzed analogue
PEI-PROP-31 was inactive. Thus, low amounts of negatively
charged groups on the polymer were able to improve the
efficiency of PEI in siRNA delivery, whereas high amounts of
negative charges resulted in nontoxic but also ineffective
polymers.
Even with lower amounts of siRNA significant knockdown
was achieved, if the polymer amount remained on the same
level (Figure 5). At concentration of the polymers in transfection
medium of 20 µg/mL and siRNA concentration of 50 nM, it
was possible to achieve 50-80% knockdown of the luciferase
gene. Decrease of siRNA concentration led to a certain increase
of the toxicity of the formulations with most of the polymers,
which was caused by an increasing amount of uncomplexed
PEI in the transfection medium. Only PEI-SUC-9 was able to
show up to 80% knockdown without any sign of toxicity at 50
nM siRNA concentration. Unmodified PEI at concentration of
2.5 µg/mL was taken as a control. As is seen, PEI was not
efficient at any siRNA concentration. Higher concentrations
showed unspecific knockdown due to the toxicity of the carrier.
PEI-SUC-9, as the most promising candidate, was additionally
tested for siRNA delivery to another stably transfected cell line
HUH7Luc (Supporting Information Figure 3). Also on this cell
line, high efficiency and low toxicity of this carrier were
demonstrated.
Bolcato-Bellemin et al. (15) postulated that the limited
efficiency of PEI/siRNA formulations might be caused by low
binding affinity of polycation to nucleic acid. Therefore, if the
binding to PEI could be increased, the formulation with siRNA
would gain efficiency. The modifications of PEI used in the
present paper were not expected to increase the binding with
siRNA. Nevertheless, several of the modified polymers showed
strongly improved siRNA activity in comparison to that of PEI.
To study this discrepancy and further define the influence of
PEI modification on the binding between polymer and siRNA,
the stability of the polyplexes against dissociation induced by
salt was studied.
Electrostatic interactions between polycations and nucleic
acids are largely responsible for the stabilization of polyplexes.
Contrary to long nucleotide sequences (like plasmids), for
relatively short oligomers the stabilization is expected to be
dependent on the number of charges per nucleic acid molecule.
Low molecular salt is able to screen the electrostatic interactions
and, at certain concentration, cause the dissociation of poly-
Figure 4. siRNA delivery to Neuro2A/EGFPLuc cells using modified PEI: (a) EA series, (b) PROP series, (c) AC series, (d) SUC series. The
numbers on the x-axis represent the polymer/siRNA w/w ratios. The final siRNA concentration in culture medium was 380 nM. White bars, LucsiRNA;
black bars, MutsiRNA. Luciferase expression levels are presented in % relative to untreated control cells. Luciferase expression was measured 48 h
after transfection without change of the medium.
Figure 5. siRNA delivery to Neuro2A/EGFPLuc cells using modified
PEI. The numbers on the x-axis represent the concentration of siRNA
in culture medium. The concentration of PEI-EA-18, PEI-PROP-18,
PEI-AC-22, and PEI-SUC-9 was kept constant at 20 µg/mL. The
concentration of unmodified PEI was kept at 2.5 µg/mL. White bars,
LucsiRNA; black bars, MutsiRNA. Luciferase expression levels are
presented in % relative to untreated control cells. Luciferase expression
was measured 48 h after transfection without change of the medium.
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plexes. The salt concentration required for the dissociation could
be attributed to the stability of polyplexes. Photon correlation
spectroscopy was used to detect the dissociation point. The
polyplexes formed in salt-free buffer were titrated with NaCl.
After each step, dynamic light scattering measurements were
performed. Addition of NaCl to the polyplex solution led to
aggregation of small polyplex particles, increase of scattering
intensity, and shift of the correlation function to the slow-motion
range (Supporting Information Figure 1). Further increase in
NaCl concentration led to the dissociation point, where the
scattering intensity drops to the level of NaCl buffer. The
residual correlation is mainly caused by the statistically low
number of foreign particles in the solution (i.e., dust) (Supporting
Information Figure 1).
The NaCl concentrations required for the dissociation of the
polyplexes with DNA and siRNA are presented in Figure 6.
As expected, polyplexes with DNA dissociate at near two times
higher salt concentration than polyplexes with siRNA. However,
no correlation between the stability and knockdown efficiency
within siRNA polyplexes was found, since all series of PEI
modifications were found to show the efficient knockdown of
the luciferase gene. According to the stability data, EA and
PROP series showed lower stability than PEI, whereas in case
of AC and SUC series, the stability was higher. The same
dependence could be also attributed to the polyplexes with DNA.
The reasons for the increased stability of the polyplexes in AC
and SUC series are not clear. Additional stabilization of the
polyplexes might be mediated through the hydrogen bonding
between the amides in these structures and the nucleic acids
(24).
Interestingly, the PEI-SUC-19 was able to transfect the cells,
but was completely inefficient in inducing knockdown with
siRNA (Figure 4d). Data from Figure 6 explain this behavior.
While being relatively stable with DNA, siRNA polyplexes of
this polymer are unstable at physiological salt concentration and
not able to induce knockdown.
DISCUSSION
In this study, a number of PEI-based polymers were synthe-
sized, which showed significantly lower toxicity in comparison
to branched PEI. Since toxicity of PEI is mainly associated with
the high positive charge of the polymer, the screening of PEI
amines was performed in different ways. The Michael addition
of ethyl acrylate (EA series) represents a relatively soft
modification, which results in transformation of primary amines
of PEI to secondary. Also, a bulky EA group is introduced to
the structure, which could represent a steric barrier for interac-
tion of PEI with negatively charged surfaces. The AC modifica-
tion reduces the positive charges of PEI due to acetylation of
primary amines. In the PROP series, the transformation of
primary to secondary amines was combined with the introduc-
tion of negatively charged proionic acid residues. Finally, SUC
series represent the strongest reduction of the positive charge
of PEI by combination of acylation of primary amines and
introduction of negative charges into the polymer.
As expected, the toxicity of the polymers was greatly reduced
by the modifications. Even the softer PEI modifications (EA,
AC) reduced the toxicity, although to a lower extent in
comparison to the PROP and SUC series. These data fit very
well with literature, where several modifications of branched
PEI led to decreased charge and lower toxicity of the
polymer (17, 25). The reduction of positive charge, however,
might also reduce activity of polycation in nucleic acid transfer
as previously reported (13, 14, 19). Within our series of
modifications, only two products with the highest degrees of
modification showed inactivation: PEI-PROP-31 for both DNA
and siRNA transfer, and PEI-SUC-19 for siRNA transfer.
Reduced polyplex stability due to the increased density of
negative charges on the cationic polymer chain is presumably
responsible for this. For example, polyplexes of siRNA and PEI-
SUC-19 dissociated in physiological saline. All other modified
PEI products were found to show transfection efficiency with
DNA comparable to that of unmodified PEI. Importantly, in
contrast to unmodified PEI, they were able to induce efficient
siRNA-mediated knockdown. PEI-SUC-9 was found to be the
most effective delivery agent for siRNA. Low toxicity and high
efficiency in knockdown, also at low concentrations of siRNA,
make this PEI modification very promising for in vitro delivery
of siRNA.
Possible reasons for the low efficiency of unmodified PEIs
in siRNA delivery despite their high efficiency in DNA transfer
might be associated with the stability of the polyplexes.
Requirements for delivery of DNA and siRNA are different.
DNA transfer requires nuclear uptake with subsequent unpack-
ing and release of the plasmid. Relatively strong binding of the
carrier to the pDNA might prevent the unpacking and degrada-
tion of pDNA in the cytoplasm. In case of siRNA delivery, an
effective dissociation from the carrier is required within the
cytoplasm. Therefore, the modifications should aim at a lower
affinity of the polymer to siRNA in comparison to DNA
polypexes. Another hypothesis postulates that lower affinity of
siRNA to the carrier as compared to plasmid DNA may be the
reason for insufficient knockdown due to polyplex instability.
Therefore, in order to achieve effective knockdown formulations,
the stability of the polyplexes with siRNA should be increased.
Neither of the two hypotheses seems to be true. According
to the data of the present investigation, the stability of the
polyplexes with siRNA is lower in comparison to the polyplexes
with DNA. Although all PEI modifications in this study were
expected to reduce the electrostatic affinity to nucleic acids,
certain series (AC and SUC) showed even higher stability of
polyplexes in comparison to unmodified PEI. Taking into
account that all modification types were able to induce
significant knockdown, AC and SUC series do not fit the first
hypothesis as well as EA and PROP series to the second. The
stability of siRNA formulations could possibly play a role during
in vivo applications; however, for in vitro efficacy the extent
of polyplex stability has minor importance, unless the polyplex
is sufficiently stable to survive in the culture medium.
The most probable reason for the improved properties of
modified PEIs in siRNA delivery in comparison to unmodified
PEI is the lower toxicity of the carrier, which enables higher
Figure 6. NaCl concentrations required for dissociation of polyplexes:
gray bars, polyplexes with DNA; black bars, polyplexes with siRNA.
For details, see Experimental Section and Supporting Information.
Complexes were formed at concentration of 20 ug/mL nucleic acid
and 1/1 w/w ratio.
Modified Branched PEI as Highly Efficient siRNA Carriers Bioconjugate Chem., Vol. 19, No. 7, 2008 1453
amounts of PEI for transfection. This hypothesis is also
supported by DNA transfection data with unmodified PEI; the
increase of w/w ratio from 0.8 to 4 led to increased transfection
efficiency (and toxicity). Higher amounts of PEI in the formula-
tion and subsequently in endosomal compartments may increase
escape to the cytosol due to a stronger proton sponge
effect (26, 27). Therefore, the transfection properties of PEI can
be boosted by increasing the amount of polymer.
The concentration of PEI plays a major role for efficient
siRNA delivery. At small concentrations, unmodified PEI is not
able to facilitate significant knockdown (Figure 5). Higher
concentrations lead to high toxicity of the carrier. In the case
of modified PEIs, in particular, PEI-SUC-9, higher concentra-
tions of PEI could be applied without toxicity. At these
concentrations, even small amounts of siRNA could be applied
to decrease the activity of the target gene. Therefore, the
reduction of the toxicity has a really decisive role for the
efficiency of siRNA formulations with modified PEI.
CONCLUSIONS
The amino group modifications of branched PEI with
acetamide, -propionic acid and ethyl ester, or succinic acid as
presented in this study strongly increase the efficiency in siRNA
delivery. For example, PEI-SUC can mediate knockdown at
siRNA concentrations as low as 50 nM. The stability of
polyplexes did not correlate with the efficiency. The most
probable reason for the improved characteristics is the strongly
reduced cytotoxicity of the modified PEI, which allows the
administration of polyplexes formulated with a larger amount
of polymeric carrier.
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